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T cell receptor–major histocompatibility complex (TCR–MHC) affinities span a wide range 
in a polyclonal T cell response, yet it is undefined how affinity shapes long-term proper-
ties of CD8 T cells during chronic infection with persistent antigen. Here, we investigate 
how the affinity of the TCR–MHC interaction shapes the phenotype of memory CD8 
T cells in the chronically Toxoplasma gondii-infected brain. We employed CD8 T cells 
from three lines of transnuclear (TN) mice that harbor in their endogenous loci different 
T cell receptors specific for the same Toxoplasma antigenic epitope ROP7. The three 
TN CD8 T cell clones span a wide range of affinities to MHCI–ROP7. These three CD8 
T cell clones have a distinct and fixed hierarchy in terms of effector function in response 
to the antigen measured as proliferation capacity, trafficking, T cell maintenance, and 
memory formation. In particular, the T cell clone of lowest affinity does not home to the 
brain. The two higher affinity T cell clones show differences in establishing resident-like 
memory populations (CD103+) in the brain with the higher affinity clone persisting longer 
in the host during chronic infection. Transcriptional profiling of naïve and activated ROP7-
specific CD8 T cells revealed that Klf2 encoding a transcription factor that is known to 
be a negative marker for T cell trafficking is upregulated in the activated lowest affinity 
ROP7 clone. Our data thus suggest that TCR–MHC affinity dictates memory CD8 T cell 
fate at the site of infection.
Keywords: cD8 T  cells, Toxoplasma gondii, neurological infection and inflammation, T  cell receptor–major 
histocompatibility complex interaction, rOP7
inTrODUcTiOn
CD8 T  cells are a cornerstone of the adaptive immune defense to intracellular pathogens with 
their capacity to operate as antigen-experienced effector and memory cells. Pathogen-specific CD8 
effector T cells rapidly expand and differentiate during the acute infection, followed by a phase of 
contraction and development of long-lived memory T cells (1, 2). Most of our understanding of 
T cell responses to chronic infections is derived from models where pathogen control is incomplete 
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and T cell become functionally impaired or exhausted over time 
(3, 4). We thus lack knowledge of what drives long-lasting control 
of chronically persistent pathogens.
The interaction of the T cell receptor (TCR) with the pathogen 
antigenic epitope loaded on the major histocompatibility complex 
(MHC) is essential in maintaining effective CD8 T cell control 
of persistent intracellular pathogens. The aβ TCR stochastically 
assembles and is selected during thymic development, and it is 
via this receptor that the immune system tunes the breath and 
strength of its response (2, 5). Efforts have been made to elicit the 
effect of TCR–MHC affinity on the fate of the resulting T cells, 
however, often this relied on varying the antigenic peptide rather 
the TCR (2, 6). The simple question of how T cells of different 
affinity to a given antigen fare during chronic infection remains 
unresolved.
To model a persistent chronic infection, we deemed a resistant 
mouse strain infected with the protozoan parasite Toxoplasma 
gondii to be most suitable. Toxoplasma is the most common 
parasitic infection in man, whereby in immunocompetent hosts 
the acute phase of infection is generally asymptomatic and pro-
ceeds to the chronic phase, which is incurable and defined by 
tissue cyst formation preferably in the brain. The parasite poses a 
serious health threat to immunocompromised individuals, espe-
cially AIDS patients. It is unclear how Toxoplasma maintains the 
intricate balance between survival and host defense. CD8 T cells 
and their ability to produce IFNγ have been shown to secure the 
latency of the parasitic infection (7, 8).
Mice harboring the MHCI allele H-2Ld (e.g., BALB/c) con-
trol Toxoplasma infection due to an immunodominant epitope 
derived from the GRA6 parasite protein (9–11). BALB/c mice 
exhibit very few tissue brain cysts and the functionality of their 
CD8 T cells in the Toxoplasma-infected brain is defined by their 
capacity to produce IFNγ and perforin (7, 12, 13). Recently, using 
the murine BALB/c chronic Toxoplasma model, a T cell popula-
tion (Tint) in an intermediate state between effector and memory 
status was discovered, highlighting the value of this model for 
defining the fate of CD8 T  cells during chronic infection with 
persistent antigen (14).
In addition to classical memory T-cell populations, a distinct 
memory T-cell population termed resident memory T cells (TRM) 
has recently been documented. TRM cells persist long term within 
non-lymphoid tissues, are resident in nature, self-renewing, and 
highly protective against subsequent infections (15, 16). These are 
and can be identified by CD103 expression (17, 18). Most TRM cells 
to date have been characterized in mucosal tissue sites, where they 
are rapidly active against secondary infections (19–21). Much 
less is known about TRM in the CNS. Viral models have defined 
CD8 TRM in VSV encephalitis and in inoculation with LCMV 
(15, 20–22). In a susceptible C57BL/6 model of Toxoplasma infec-
tion, a transcriptionally defined resident memory CD8 population 
was recently defined in the brain (23). Again, prerequisites in 
terms of TCR–MHC affinity for the transition of CD8 T cells to a 
TRM phenotype are completely unexplored.
Rather than varying the antigenic peptide, we sought to 
use distinct clonal T  cells. To answer how TCR–MHC affinity 
dictates trafficking and phenotype of memory CD8 T  cells in 
the brain during chronic infection, we employed three distinct 
clonal CD8 T cells, each expressing a natural TCR recognizing 
the Toxoplasma antigen ROP7 (24, 25). These cells were obtained 
from transnuclear (TN) mice generated by somatic cell nuclear 
transfer from a nucleus of a Toxoplasma antigen-specific CD8 
T cell and have different affinity for MHC class I loaded with the 
same ROP7 peptide (24, 25).
Here, we report that TCR–MHC affinity dictates the potential 
of a CD8 T cells to home to the Toxoplasma-infected brain. We 
employed three natural CD8 T cell clones derived from a resolv-
ing Toxoplasma infection by somatic cell nuclear transfer, defined 
to possess different affinities for the same Toxoplasma antigen 
ROP7 (24, 25). The two T cell clones with higher affinity, R7-I and 
R7-III, were found in the brain during chronic infection, while 
the lowest affinity clone R7-II was not, despite all three clones 
being activated during the acute phase of infection. As possible 
causes for this divergent homing, we observed high expression of 
the negative regulator of T cell activation Klf2 and its regulated 
genes in peptide-activated R7-II T  cells. In addition, Ctla4, a 
negative regulator of T cell responses, was also upregulated on 
R7-II T  cells. The highest affinity clone, R7-I, persisted longer 
during the chronic phase of infection than R7-III and was able 
to generate more CD103+ T cells in the brain. Thus, our results 
indicate that higher affinity of the TCR–MHC interaction is 
better for trafficking and persisting of the specific CD8 T cells at 
the site of chronic infection, here brain.
MaTerials anD MeThODs
Mice
Thy1.1 (BALB/c N4; CD90.1+) and TN R7-I, -II, and -III mice 
on a Rag2 proficient BALB/c (Rag2+/+CD90.2+) background 
were housed and bred in the animal facility of the Francis Crick 
Institute (Mill Hill Laboratory, London, UK) (24). All procedures 
involving mice were approved by the local ethical committee of 
the Francis Crick Institute Ltd., Mill Hill Laboratory and are part 
of a project license approved by the Home Office, UK, under the 
Animals (Scientific Procedures) Act 1986.
calcium Flux assay
For calcium flux measurements, lymphocytes from lymph 
nodes (LN) of R7-I, -II, or -III mice were isolated and loaded 
with Indo-1 dye (Life Technologies) at concentration of 2 mg/ml 
in IMDM media containing 5% FCS for 40  min at 37°C. 
Subsequently, cells were washed two times with IMDM media 
and stained with anti-CD8 (53-6.7), anti-CD4 (GK1.5), and 
anti-CD3 (17A2) antibodies all from BioLegend (San Diego, CA, 
USA) for 20 min at room temperature. Lymphocytes were then 
stimulated by addition of ROP7–MHCI dextramer (Immudex) or 
by addition of Ionomycin (10 ng/ml).
erK1/2 Phosphorylation assay
For the ERK1/2 phosphorylation assay, lymphocytes from LN of 
R7-I, -II, or -III mice were isolated and stained with anti-CD8 
(5H10, Invitrogen) and anti-CD4 (GK1.5, BioLegend) antibodies. 
Splenocytes loaded with ROP7 peptide were used as stimulators. 
Lymphocytes were then stimulated by addition of splenocytes 
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and incubated for 0, 1, 2, 4, 8, and 12 min at 37°C. At the indicated 
time points, cells were fixed with paraformaldehyde at a final con-
centration of 2%. Cells were permeabilized by addition of ice-cold 
90% methanol and stored over night at −20°C. Next, cells were 
washed and stained with anti-pERK1/2 (pT202/pY204) (20A, BD 
Biosciences) and acquired using an LSR II flow cytometer. Data 
were analyzed using FlowJo and Prism software.
In Vitro Proliferation assay
Splenocytes of R7-I, -II, and -III mice were isolated, stained with 
the intracellular fluorescent dye carboxyfluorescein diacetate 
succinimidyl ester (CFSE; 5 µM; Life Technologies) for 5 min at 
room temperature, and plated in 96-well plates. ROP7 peptide 
was added in the range of concentrations from 0.5 ×  10−4 to 
0.5 × 10−9 M. Three days later, cells were harvested and stained 
for FACS analysis.
T cell adoptive Transfer and infections
Lymph nodes and spleens from TN ROP7 donor mice were har-
vested and the released cells negatively selected for CD8 T cells. 
Recipient Thy1.1 (BALB/c) mice received 106 ROP7+ CD8 T cells 
via i.v. injection prior to infection. Mice were infected orally with 
five cysts of the ME49 Toxoplasma strain. Cells were harvested at 
the indicated time points during the acute and chronic phases of 
infection and processed accordingly.
isolation of Brain Mononuclear cells
Isolation of brain mononuclear cells was performed as described 
before (26). Briefly, mice were perfused with cold PBS, and 
brains were isolated and homogenized. Brain cell suspension was 
diluted to 30% with isotonic Percoll solution and layered on top 
of 70% isotonic Percoll solution. Gradients were spun for 30 min 
at 500 × g, 18°C. Mononuclear cell population was collected from 
the interphase of Percoll gradient, washed and resuspended for 
antibody staining or restimulation.
In Vivo Proliferation assay
ROP7 CD8 T cells were prepared as described. Prior to subcuta-
neous injection into recipient mice, cells were stained with CFSE 
(5 µM). Mice were then infected orally as described. Spleen, LN, 
and mesenteric LN (mLN) tissues were then harvested 6/7 days 
post-infection (p.i.) and processed accordingly.
Ex Vivo Functional assay
Cells harvested from mice 3 weeks p.i. were cultured ex vivo as 
a cell suspension for 2 h with Ionomycin (20 ng/ml) and PMA 
(1 µg/ml) after which Brefeldin A (2 µg/ml) was added for the 
next 2 h in RPMI media. Cells were then stained for flow cytom-
etry and analyzed as described.
Micropipette Two-Dimensional adhesion 
Frequency assay
The two dimensional affinities were measured by micropipette 
adhesion frequency assay (27). CD8 T  cells were negatively 
selected by magnetic cell sorting (Milteney) from spleen and 
LN of TN ROP7 mice. Human red blood cells (RBCs) were 
isolated in accordance with the Institutional Review Board 
at Emory University and used as the surrogate APC sensor 
through incorporation of ROP7 monomers with mouse β2-
microglobulin (National Institutes of Health Tetramer Core) via 
biotin:streptavidin interactions. RBCs were coated with Biotin-
X-NHS (EMD, Millipore) and 0.5 mg/ml streptavidin (Thermo 
Fisher Scientific) and 1–2  mg of the monomer antigenic and 
control monomers. Monoclonal cells were brought into contact 
50 times with pMHC coated RBCs with the same contact time 
and area (Ac), and the adhesion frequency (Pa) was calculated. 
Quantification of binding events along with TCR and pMHC 
surface densities and adhesion frequencies along with two-
dimensional affinity were as described (27, 28).
antibodies
Fluorescently labeled antibodies against CD3, CD90.1, CD90.2, 
CD62L, CD127, CD103, KLRG1, PD1 antigens, and IFNγ 
were purchased from BioLegend (San Diego, CA, USA). 
Fluorescently labeled antibodies against CD8 (5H10) alpha and 
anti-CD69 were purchased from Life Technologies (Carlsbad, 
CA, USA). H-2Ld monomers with IPANAGRFF or photo-cleav-
able peptide (YPNVNI(Apn)NF) were obtained from the NIH 
Tetramer Core Facility (Emory University, Atlanta, GA, USA) 
and were tetramerised and peptide-exchanged as described 
previously (29). All peptides were synthesized by Pepceuticals 
(Leicestershire, UK).
Flow cytometry
Single-cell suspensions were prepared from brain, spleen, LN, and 
mLN by mechanical disruption. Brain mononuclear cells were 
isolated as described above (26). Cell were stained for 20 min at 
4°C in an appropriate antibody cocktail and washed with PBS 
with 1% BSA. BD Cytofix/Cytoperm kit was used for intracellular 
staining of cells. Cells were run on a BD LSRII or BD Fortessa X20 
and analyzed using FlowJo software (Tree Star).
chimeras
Recipient BALB/c mice (CD90.1) were treated with an intraperito-
neal injection of myeloablative agent Busulfan (10 mg/kg, Busilvex, 
Pierre Fabre) and injected with a congenic (CD90.2) donor bone 
marrow (BM) from ROP7 TN mice 1 day after to create BM chime-
ras. 6–8 weeks after BM transplantation chimerism was assessed in 
the blood to be up to 5% donor CD8 of total CD8 T cells. Donor 
CD8 T cells were 60–80% of total CD8 T cells in the thymus. Mice 
were infected orally with five cysts of Toxoplasma ME49.
rnaseq analysis
Single-cell suspensions of splenocytes from R7-I, -II, or -III 
mice were incubated in RPMI medium 1640 supplemented with 
recombinant mouse IL-2 (10 ng/ml) overnight at 37°C with or 
without ROP7 peptide (10  µM). Cells were stained with live/
dead, anti-CD3, anti-CD8a, and ROP7 tetramer. Live CD8+ 
tetramer+ T cells were sorted on the Aria, XDP, and Influx 1 cell 
sorters. Samples were maintained at 4°C and purity determined 
to be 90–95%. RNA was isolated using Trizol and the RNeasy 
Micro-Kit (Qiagen). A total of 200 ng of RNA was used to pre-
pare the RNA library using TruSeq mRNA Library Prep Kit v2 
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(Illumina) according to the manufacturer’s recommendations. 
RNA sequencing was performed on the Illumina HiSeq 2500 
and typically generated ~25 million 100-bp non-strand-specific 
single-end reads per sample. The RSEM package (version 1.2.11) 
(30) was used for the alignment and subsequent gene-level 
counting of the sequenced reads relative to mm10 RefSeq genes 
downloaded from the UCSC Table Browser (31) on May 27, 2015. 
Differential expression analysis between the triplicate groups 
was performed with DESeq2 (version 1.8.1) (32) after removal 
of genes with a maximum transcript per million (TPM) value 
of 1 across all samples in the experiment. Significant expression 
differences were identified at a false discovery rate threshold 
of 0.01. Gene set enrichment analysis was performed by Gene 
Ontology Biological processes using GeneGo MetaCore (https://
portal.genego.com/). All raw RNASeq sequence data and per 
sample TPM counts generated by RSEM can be accessed with 
GEO accession GSE88996 and GSE113827. Pathway analysis 
was performed using IPA software to demonstrate the biological 
effect of differentially expressed genes on cell cycle progression.
real-Time Pcr
RNA was extracted from ROP7-specific splenocytes, either 
straight from the spleen or incubated overnight with or without 
ROP7 peptide using RNeasy Mini and Micro Kits (Qiagen). cDNA 
was synthesized using the Maxima first strand cDNA synthesis kit 
for RT-qPCR, with dsDNase (Thermo Fisher Scientific).
Quantitative real-time PCR was performed using Maxima 
SYBR Green/Rox qPCR master mix (Thermo Fisher Scientific).
Results were normalized to the expression of CD8. Relative fold 
change was calculated by normalizing to the average of R7-I, R7-II or 
R7-III biological triplicates, respectively (straight from the spleen).
Primers used were as follows: KLF2 forward 5′-TGT 
GAGAAATGCCTTTGAGTTTACTG-3′, reverse 5′-CCCTTAT 
AGAAATACAATCGGTCATAGTC-3′, CXCR3 forward 5′-GC 
CAAGCCATGTACCTTGAG-3′, reverse 5′-GTCAGAG 
AAGTCGCTCTCG-3′, Sell forward 5′-ACGGGCCCCAG 
TGTCAGTATGTG-3′, reverse 5′-TGAGAAATGCCAGCCCC 
GAGAA-3′, S1P1 forward 5′-GTGTAGACCCAGAGTCCTG 
CG-3′, reverse 5′-AGCTTTTCCTTGGCTGGAGAG-3′, IL-6Rα 
forward 5′-GTCACGGGCACTCCTTGGATAG-3′, reverse 5′-AG 
GAATGTGGGCAGGGACATGG-3′, Itag4 forward 5′-GATG 
CTGTTGTTGTACTTCGGG-3′, reverse 5′-ACCACTGAGGC 
ATTAGAGAGC-3′, CXCR4 forward 5′-GACTGGCATAGTCG 
GCAATG-3′, reverse 5′-AGAAGGGGAGTGTGATGACAAA-3′, 
IL-7Rα forward 5′-GCGGACGATCACTCCTTCTG-3′, reverse 
5′-GCATTTCACTCGTAAAAGAGCCC-3′, CD8 forward 5′-GA 
TATAAATCTCCTGTCTGCCCATC-3′, reverse 5′-ATTCATAC 
CACTTGCTTCCTTGC-3′.
statistical analyses
GraphPad software (Prism) was used to perform statistical tests. 
Comparisons between two groups were made using Student’s 
t-test. Comparisons between multiple groups were made using 
one-way analysis of variance test. Levels of significance are denoted 
as follows: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, and ****p ≤ 0.0001. 
Non-significant results are either not marked or indicated as NS.
resUlTs
Three cD8 T cell clones specific for  
the same Peptide respond Differently  
to In Vitro Tcr stimulation With  
cognate antigen
We previously described TN mouse lines (24), which we used 
herein as a source of three CD8 T cell clones specific for the same 
peptide (IPAAAGRFF) derived from the ROP7 protein of T. gon-
dii. We refer to these CD8 T cell clones as R7-I, R7-II, and R7-III 
CD8 T cells (24). We previously showed these CD8 T cell clones 
to differ in their TCR 3D affinity to cognate ROP7 peptide, with 
R7-I being the strongest binder at 4 µM and R7-II the weakest at 
109 µM. R7-III has a binding affinity of 24 µM (25). To further 
define the kinetics of TCR signaling after stimulation with ROP7 
peptide, we measured ER-driven calcium release, phosphorylation 
of ERK1/2 kinase, and cell proliferation as determinants of TCR 
reactivity. Both the calcium release and phosphorylation assays 
reflected the hierarchy of the TCR–MHC binding 3D affinity and 
were the fastest and strongest in R7-I CD8 T cells, while the R7-II 
CD8 T cell response was lowest (Figures 1A,B). In addition, we 
noted that R7-II CD8 T cells had a basal level of free intracellular 
calcium that was higher than that of R7-I and R7-III CD8 T cells 
(Figure 1A). As a positive control, we used CD3 cross-linking to 
stimulate R7 cells (Figure S1 in Supplementary Material). All three 
clones are able to phosphorylate ERK1/2 kinase equally upon CD3 
cross-linking (Figure S1A in Supplementary Material). Calcium 
release upon CD3 cross-linking was lower for R7-II and equal 
for R7-I and R7-III (Figure S1B in Supplementary Material). In 
the in vitro proliferation assay, R7-II CD8 T cells were not able to 
proliferate efficiently even at the highest (500 µM) concentration 
of ROP7 peptide loaded onto splenocytes, while R7-I and R7-III 
CD8 T cells reached the highest division index at concentrations 
5 and 0.5 µM, respectively (Figure 1C). We previously conducted 
ex vivo proliferation experiments of R7 CD8 T cells crosslinked 
on plate-bound CD3/CD28 and concluded that R7-II cells barely 
proliferated at all (25). Combined, these in  vitro experiments 
suggest that the 3D surface plasmon resonance affinity of the 
TCR–MHC binding reflects the strength of downstream signal-
ing and partially translates to proliferation capacity in vitro.
To provide additional insight into the functional response of 
the three R7 CD8 T cell clones during Toxoplasma infection, we 
determined their 2D affinity for the ROP7 antigen. The micropi-
pette adhesion frequency assay provides 2D-based measures of 
TCR affinity for pMHC in a context that is membrane anchored. 
2D affinity correlates more closely to functional responses than 
do 3D affinity measurements whose measurements are based on 
purified proteins. Over 40 T cells for each clone were analyzed to 
reveal similar high affinities for R7-I and R7-III (geometric means 
being 1.38E−04 and 1.27E−04, respectively) and that R7-I whilst 
having a similar affinity to R7-III (Figure 1D) has a higher adhe-
sion frequency than R7-III (Figure 1E) that being 0.91 and 0.81, 
respectively. R7-II had a threefold lower 2D affinity (7.01E−05). 
The threefold difference in affinity is functionally relevant as 
previously, we have demonstrated that during Polyoma infection 
CD8 T cells with the highest 2D affinity are found in the CNS 
FigUre 1 | Three distinct CD8 T cell clones of the same specificity exhibit different 2D affinity and responses to specific TCR receptor stimulation. (a) Ca2+ flux 
profile of the three R7 CD8 T cell lines upon stimulation of TCR signaling with ROP7 dextramer (representative of two experiments with multiple mice each).  
(B) Phosphorylation of ERK1/2 kinase in time upon stimulation with splenocytes loaded with ROP7 peptide (representative of two experiments). (c) Proliferation of 
R7 CD8 T cells after stimulation with a range of ROP7 peptide concentrations (representative of three experiments). (D) Relative 2D affinity of the three R7 CD8 T cell 
clones specific for ROP7 (IPAAAGRFF) normalized by TCR surface density. Each individual data point represents the affinity for a single CD8 T cell. Analysis utilizes 
the geometric mean of the population. (e) Adhesion frequencies of the three ROP7 clones F. Gaussian curves were fitted to the affinities of (D). Blue line represents 
R7-I, red line represents R7-II, and the green line represents R7-III. Data are cumulative from two individual experiments and a total of three mice per clone.
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and eventually comprise the TRM population (33). In addition, we 
have reported CD4 T cells mediating EAE carry a twofold higher 
affinity when compared with the peripheral T cells (34).
all Three clones of r7 cD8 T cells are 
efficiently Primed in the acute Phase  
of T. gondii infection
Next, we sought to verify if these differences observed in  vitro 
would still hold true in  vivo. R7 CD8 T  cells were adoptively 
transferred into congenic naïve recipient mice (CD90.1 BALB/c). 
Subsequently, mice were orally infected with ME49 Toxoplasma 
tissue cysts. The donor R7 CD8 T cells could then be followed 
during the acute and chronic phase of infection (Figure 2A). We 
were able to observe proliferated cells for all three R7 clones in 
the mLN earliest 6 days p.i. (Figure 2B). The numbers of R7-II 
donor cells found in the mLN and spleen were at least 10 times 
lower than numbers of other two clones (Figure 2B). However, 
those R7-II cells that were recovered from mLN had low CFSE 
level indicating that they had proliferated similarly to R7-I 
and R7-III CD8 T cells. In addition, the R7 donor CD8 T cells 
were all activated to the same extent based on CD69 expression 
FigUre 2 | Three clones of R7-reactive CD8 T cells are primed and activated during the acute phase of Toxoplasma gondii infection. (a) Schematic diagram of the 
experimental setup for in vivo experiments. Transnuclear R7 mice were used as a donor of CD8 T cells in adoptive transfer experiments (AT). CD8 T cells isolated 
from lymph nodes (LN) and spleens were transferred to congenic recipients. Recipient mice were infected orally with five cysts of Toxoplasma ME49. At different 
time points post-infection (p.i.) recipient mice were sacrificed and donor CD8 T cell populations were assessed. (B) Donor cells were stained with CFSE before 
transfer. Histograms show CFSE dilution and CD69 expression on transferred R7 CD8 T cells isolated from mesenteric LN (mLN) 6 days p.i. via the oral route 
(representative of two independent experiments).
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(Figure 2B). We conclude that all three R7 clones are responsive 
to a Toxoplasma infection in vivo, as measured by proliferation 
and activation status.
r7-ii cD8 T cells Do not Persist and Do 
not reach the Brain of recipient Mice 
During T. gondii infection
Cysts in the brain characterize the chronic phase of Toxoplasma 
infection. IFNγ produced by CD8 T  cells is crucial for the 
maintenance of the quiescent cyst form of Toxoplasma (8, 13). 
We showed that the three R7 CD8 T cell clones could be primed 
and proliferated in the acute phase of Toxoplasma infection. 
Next, we investigated if R7 CD8 T  cells could be found in the 
brain in the chronic phase of Toxoplasma infection. We analyzed 
brain, spleen, mLN, and non-draining LN for the presence of 
transferred R7 CD8 T  cells 3  weeks p.i. R7-I and R7-III CD8 
T cells were found in significant numbers in the brain at 3 weeks 
p.i. (Figure 3A). Percentages and absolute numbers of donor R7 
CD8 T  cells of all CD8 T  cells in a given organ were different 
depending on the clone (Figure 3A). The R7-II clone was found 
in insignificant percentages and numbers in all tested organs. 
R7-I and R7-III clones were present in higher percentages from 
2 to 15% of all CD8 T cells depending on the organ. There was 
no significant difference between percentages of the R7-I and 
R7-III clone in the brain. In the spleen and mLN, we observed 
significantly higher percentages of the R7-III CD8 T  cells. We 
also determined absolute cell number for each clone at each site 
and did not observe significant differences between the R7-I and 
R7-III clone (Figure 3A, right panel).
We analyzed earlier time points to estimate the time when 
donor cells reached the brain and to assess if there is a difference in 
donor cell number or percentages in the acute phase of infection. 
R7-I and R7-III CD8 T cells were observed in the brain as early as 
FigUre 3 | Continued
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TaBle 1 | Top 10 up and downregulated genes in activated R7-II vs R7-I and 
R7-III.
gene symbol Fc FDr
Up in r7-ii (Fc > 2,531 genes)
1 Tnfrsf19/CD137 19.20 5.84E−105
2 Mturn 14.93 1.95E−77
3 Rasgrp2 13.49 1.27E−90
4 Slc6a19 12.84 2.18E−44
5 Cd7 11.38 4.03E−49
6 S1pr1 9.77 1.21E−44
7 Nsg2 9.68 3.28E−34
8 Klf2 8.80 4.88E−149
9 Atp6v0e2 8.60 1.18E−29
10 Arl4c 8.45 5.70E−105
Down in r7-ii (Fc > 2,119 genes)
1 Tbx21/Tbet −6.45 4.64E−38
2 Tnfsf11/RANKL −6.07 5.80E−160
3 Serpinb6b −5.64 2.11E−42
4 Dapl1 −5.51 1.15E−38
5 Ccl9 −5.46 3.81E−93
6 Rnf157 −4.89 5.80E−78
7 Tbkbp1 −4.51 2.74E−32
8 Lipg −4.51 4.47E−72
9 Stc2 −4.14 8.38E−16
10 Chst11 −3.95 1.98E−56
Table shows top 10 up- and downregulated genes in R7-II samples as compared with 
R7-I and R7-III samples upon activation, where only genes differentially expressed in 
R7-II vs R7-I and R7-II vs R7-III comparisons but similar expression between R7-I  
and R7-III were included. For each gene in the table, fold change (FC) and false 
discovery rate (FDR) are shown for R7-II vs R7-III comparison.
FigUre 3 | R7-II CD8 T cells do not persist and do not reach the brain of recipient mice during Toxoplasma gondii infection. (a) Percentages and total cell numbers 
of donor R7 CD8 T cells in the brain and lymphoid organs 3 weeks post-infection (p.i.) (representative of at least five experiments with three mice per line), only 
significant relationships between R7-I and R7-III CD8 T cells are shown, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, two-way analysis of variance (ANOVA) followed by 
multiple comparisons Tukey’s. Mean and SD. (B) Percentages and cell numbers of donor R7 CD8 T cells in the brain and spleen in the acute phase of infection  
(day 10 p.i.) (representative of two experiments), *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, one-way ANOVA followed by multiple comparisons Tukey’s. Mean and SD.  
(c) Splenocytes of R7 mice were left untreated (unstimulated) or stimulated with the Rop7 peptide (activated) over night. On the next day, ROP7tet+ CD8 T cells 
were sorted and lysed for RNA extraction. Transcripts levels were evaluated in an RNAseq experiment. Klf2 was upregulated in activated R7-II by a fold change of 
8.8 over activated R7-III (Table 1). Expression of Klf2 and Klf2-regulated genes is shown as transcript per million (TPM) in unstimulated and activated (left hand 
graph) or only activated R7 CD8 T cells (right graph). (D) Validation of RNAseq results was performed on samples from an independent experiment with use of 
qRT-PCR. Expression of Klf2 and Klf2-regulated genes shown as normalized 2−ΔΔCt values. *p ≤ 0.05, one-way ANOVA followed by multiple comparisons Tukey’s. 
Mean and SD. (e) CTLA4 expression in the RNAseq experiment shown as TPM value in activated samples (left graph) and CTLA4 protein expression evaluated by 
FACS of cells isolated 5 days p.i. from lymph nodes (LN) of mice adoptively transferred with R7 cells and infected with Toxoplasma (right graph). *p ≤ 0.05, 
**p ≤ 0.01, ***p ≤ 0.001, one-way ANOVA followed by multiple comparisons Tukey’s. Mean and SD.
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10 days p.i., however, we failed to detect a distinct R7-II CD8 T cell 
population in the brain (Figure 3B). R7-II CD8 T cells could not 
be observed in prominent numbers in any of the tested primary 
and secondary lymphoid organs suggesting a lack of proper 
expansion and thus an absence of the transferred population in 
the brain (Figure  3B; Figure S2A in Supplementary Material). 
Combining our previous observations of the low TCR–MHC 
affinity of R7-II cells (Figures  1D,E) and the low proliferation 
in response to in vivo stimulation during a Toxoplasma infection 
(Figure  2B), we concluded that R7-II cells most likely fail to 
expand sufficiently in secondary lymphoid organs to efficiently 
home to the brain. R7-I and R7-III CD8 T cells were a major part 
(60–80%) of the total CD8 T cell population in the brain at day 10 
p.i. Their percentages decreased throughout time during which 
host CD8 T cells reached the brain suggesting that the transferred 
T cell clones exhibited a rapid recruitment to the brain compared 
to newly formed Toxoplasma-specific CD8 T  cells of the host. 
There were no significant differences in percentages or numbers 
of donor population between R7-I and R7-III CD8 T  cells at 
day 10 or 2 weeks p.i. (Figure 3B; Figure S2A in Supplementary 
Material).
To dissect the reasons for the poor expansion and lack of 
R7-II cells in the brain we compared the transcriptional profiles 
of in  vitro ROP7-activated R7-II vs R7-I or R7-III cells. As 
expected, the global gene expression differences were much more 
pronounced when peptide-activated R7-II cells were compared 
with R7-I and R7-III (Figure S3 in Supplementary Material). In 
the list of the top 10 genes upregulated in R7-II (Table  1), we 
found Klf2 encoding a transcription factor that is known to be 
important for T cell trafficking between the blood and lymphoid 
organs (35–37). Klf2 is highly expressed in naïve and memory 
T cells but downregulated in effector T cells upon binding of the 
TCR to its cognate peptide (38). The stronger the binding affinity, 
the lower the expression of Klf2 and the better the activation of 
the T cells (39). In addition, S1pr1 which is regulated by Klf2 was 
also in the top 10 upregulated genes. We analyzed the expres-
sion of Klf2 across the unstimulated and activated samples of the 
RNASeq experiment (Figure 3C, left graph) as well as at the genes 
known to be regulated by Klf2 such as CXCR3, Sell (CD62L), 
S1pr1, Itga4, CXCR4, Il7ra, and Il6ra (Figure 3C, right graph). 
Klf2 expression was at similar level in all three naïve CD8 T cell 
clones. After activation, all three clones downregulated Klf2, 
however, downregulation in R7-II was the weakest reflecting the 
lowest binding affinity of Rop7 peptide to R7-II. Expression of 
Sell (CD62L), S1pr1, Itga4, CXCR4, Il7ra, and Il6ra mirrored Klf2 
expression being highest in R7-II and was comparable between 
R7-I and R7-III. On the other hand, CXCR3 expression was lowest 
in R7-II. We performed an independent in  vitro activation 
experiment and observed a similar trend of gene expression by 
qRT-PCR as seen in the RNAseq results (Figure  3D). mRNA 
expression detected by qRT-PCR correlated with the RNAseq 
data for all tested genes except the CXCR3 gene.
CTLA4 is known as a negative regulator of T cell responses. 
We analyzed the expression of the Ctla4 transcript in the RNASeq 
of activated ROP7 CD8 T  cells as its high expression in R7-II 
cells could explain their poor performance in proliferation capac-
ity and subsequent lack of homing to the brain. As expected, 
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we observed the highest expression of Ctla4 in R7-II CD8 T cells in 
comparison with the two other R7 clones (Figure 3E, left graph). 
We could confirm the RNAseq data in an in  vivo experiment, 
where R7 T cells were adoptively transferred to congenic mice and 
analyzed in LNs 5 days after infection with Toxoplasma. CTLA4 
surface expression determined by FACS in R7-II cells was highest 
in comparison to R7-I and R7-III CD8 T cell clones (Figure 3E).
r7-iii has a higher contraction rate  
and Does not Persist in the late  
Phase of chronic infection
At 5  weeks p.i. compared with 3  weeks p.i., we observed a 
dramatic decrease in the R7-III CD8 T  cell population in all 
of tested lymphoid and non-lymphoid organs while the R7-I 
CD8 T cell population decreased more subtly, which could be 
explained by natural contraction of the population after an ini-
tial expansion phase (Figure 4A; Figure S2B in Supplementary 
Material).
The formation of memory CD8 T  cells in persistent infec-
tions is still controversial (40). In BALB/c mice where persistent 
Toxoplasma infection is known to be controlled by CD8 T cells (13), 
the presence of memory CD8 T cells is expected. We analyzed if 
R7 CD8 T cells differentiated into memory cells and if the ratio of 
differentiation into effector and memory precursors was the same 
between R7-I and R7-III CD8 T cells. Short-lived effector cells 
(SLEC, CD127−KLRG1+) were present in similar percentages in 
R7-I and R7-III CD8 T cell populations in the brain and spleen 
at 3 and 4  weeks p.i. (Figure  4B). Memory precursor effector 
cells (MPEC, CD127+KLRG1−) where not present at 3 weeks p.i., 
however, we detected population of MPEC at 4 weeks p.i. in the 
spleen in similar percentages between R7-I and R7-III CD8 T cell 
(Figure 4B, bottom panel).
In the chronic phase of Toxoplasma infection in C57BL/6 
mice, CD8 T cells in the brain are exhausted and express high 
levels of the exhaustion marker PD1 (41). Blockade of the 
PD1–PDL1 pathway has been shown to rescue the exhaustion 
phenotype of CD8 T cells and prevent mortality of chronically 
Toxoplasma-infected animals (42). In contrast to C57BL/6 mice, 
BALB/c mice are resistant to chronic Toxoplasma infection (9) 
and Toxoplasma GRA6-specific CD8 T  cells in BALB/c mice 
lack PD1 expression during the chronic phase (14). We investi-
gated if R7 CD8 T cells in brain of BALB/c mice at 3 weeks p.i. 
were exhausted. Almost 90% of R7 CD8 T cells expressed PD1 
(Figure 4C). No significant difference was observed between R7-I 
and R7-III CD8 T cell populations in the brain suggesting that it 
is not exhaustion that leads to greater contraction of the R7-III 
CD8 T cell population. As PD1 can be also a marker for recently 
activated cells, we analyzed the ability of PD1+ cells to produce 
IFNγ, since cytokine production is lost in a truly exhausted cell 
(43). Brain mononuclear cells from week 3 of infection were ex 
vivo re-stimulated with PMA and ionomycin and stained for 
IFNγ (Figure 4C). More than half of PD1 positive cells were able 
to produce IFNγ and only 1/3 of R7 CD8 T cells in the brain were 
positive for PD1 and negative for IFNγ. At the same time, only 
5% of R7 cells in spleen expressed PD1 and did not produce IFNγ. 
No significant difference between R7-I and R7-III CD8 T cells 
was observed indicating that the reason for the disappearance of 
R7-III CD8 T cells is independent of their exhaustion state.
Next, we considered CXCR3 as a candidate molecule to 
unravel the differences in persistence between R7-I and R7-III. 
The CXCR3 receptor is important in trafficking of CD8 T cells 
to non-lymphoid tissues including the brain (44). We evaluated 
CXCR3 expression levels on R7-I and R7-III CD8 T cells during 
Toxoplasma infection. CXCR3 expression on R7-III CD8 T cells 
was significantly lower at day 10 p.i. both in the brain and in the 
spleen (Figure 4D). However, no difference in CXCR3 expres-
sion was observed at 3 weeks p.i., thus it is questionable if lower 
CXCR3 expression at earlier time points of infection were the 
driver for lower R7-III CD8 T cell numbers observed in the brain 
at 5 weeks p.i.
To better understand the observed decrease in the brain popu-
lation of R7-III CD8 T cells we set up BM chimeras. We used the 
transplant conditioning drug busulfan to induce myeloablation 
and create a niche for the R7-I or R7-III BM (45). In the brain and 
spleen, R7-I and R7-III BM chimeras have similar percentages of 
CD8 T cells originating from the donor’s BM at both week 3 and 
5 p.i. (Figure 4E). These results show that constant replenishment 
from the periphery is necessary for the persistence of donor cells 
is the brain at 5 weeks p.i. When R7-III CD8 T cells disappear 
from the periphery, they also disappear from the brain. By creat-
ing chimeras, we showed that when we keep a constant R7-III 
population in the periphery these cells also persist in the brain.
r7-i cD8 T cells of TrM-like (cD103+) 
Phenotype are Present in higher 
Percentages in the Brain Than  
r7-iii cD8 T cells
Previous studies have shown that tissue-resident memory T cells 
found in the brain long after acute infection has been cleared can 
survive without replenishment from the CD8 T cells circulating 
in the blood (15). We analyzed CD69+ CD103+ T  cells in our 
model of chronic Toxoplasma infection. We observed a higher 
percentage of donor CD103+ cells compared with total donor 
CD8 T cells for R7-I compared with R7-III at 3 weeks p.i. in the 
brain (Figure 5A). There was no significant difference between 
the total numbers of R7-I and R7-III CD103+ cells in the brain. At 
week 5 p.i., about 80% of R7-I cells compared to the total donor 
CD8 T  cell population had a TRM-like phenotype (Figure  5B). 
The total number of donor R7-I cells stays stable between week 
3 and 5 p.i. (Figure  4A, right), while we observed an increase 
in percentages and numbers of R7-I CD103+ cells. As expected, 
R7-III CD103+ cells at 5 weeks p.i. were not found in the brain.
We show with our BM chimera experiment that R7-III cells 
in the brain are replenished from the periphery (Figure 4E). BM 
chimeras 3 weeks p.i. also exhibited lower percentages of R7-III 
CD103+ cells in the brain (Figure 5C), suggesting that the differ-
ence to produce less TRM-like cells is intrinsic to the R7-III.
DiscUssiOn
Affinity of TCR–MHC interaction influences the fate of the acti-
vated T cell (2). Immediate effects of strong or weak interactions 
FigUre 4 | Continued
10
Sanecka et al. TCR–MHC Affinity Shapes CD8 Properties
Frontiers in Immunology | www.frontiersin.org June 2018 | Volume 9 | Article 1290
FigUre 5 | R7-I CD8 T cells of a TRM-like phenotype (CD103+) are present in higher percentages in the brain of Toxoplasma gondii-infected mice than R7-III CD8 
T cells. ROP7 CD8 T cells were adoptively transferred into congenic mice before Toxoplasma infection (a,B). (a) Representative FACS plots of donor CD103+ 
memory population in the brain at 3 weeks post-infection (p.i.) are shown on the left. Percentages and numbers of donor and host CD103+ CD8 T cells in the brain 
3 weeks p.i. are shown on the right (graphs shows pooled results from two experiments and are representative of at least five experiments with two or three mice 
each). ***p < 0.001 by Student’s t-test. (B) Percentages and numbers of donor and host CD103+ CD8 T cells in the brain 5 weeks p.i. are shown (graphs are 
representative of at least three experiments with two or three mice each). N.D. denotes populations not detected. *p ≤ 0.05, **p ≤ 0.01 by Student’s t-test.  
(c) CD103+ percentages and numbers in brains of R7 bone marrow chimeras mice 3 weeks p.i., three mice per T cell line, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001  
by Student’s t-test.
FigUre 4 | R7-III has a higher contraction rate and does not persist into the late phase of chronic Toxoplasma gondii infection. ROP7 CD8 T cells were adoptively 
transferred into congenic mice before Toxoplasma infection. Spleen, mesenteric LN and popliteal and axillary lymph nodes and brains were harvested and analyzed 
by flow cytometry (a–e). (a) Percentages and total cell numbers of donor Rop7 CD8 T cells in the brain and spleen 3 and 5 weeks post-infection (p.i.) 
(representative of at least five experiments with two or three mice per cell line per experiment). *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, two-way analysis of variance 
followed by Tukey’s multiple comparisons test. (B) Donor population was assessed for expression of CD127 (IL7Ra) and KLRG1 at 3 and 4 weeks p.i. 
(representative of at least five experiments). (c) PD1 expression on donor CD8 T cells in the brain 3 weeks p.i. and their potential to produce IFNγ after ex vivo 
restimulation with PMA/Ionomycin (representative of two experiments). *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 by Student’s t-test. (D) CXCR3 surface staining on donor 
CD8 T cells 10 days p.i. in brain and spleen together with representative histogram plots of CXCR3 expression of donor R7 CD8 T cells in the brain and spleen 
10 days p.i. (e) Percentages of R7 CD8 T cells in brain and spleen of R7 bone marrow chimeras at 3 and 5 weeks (minimum of three mice analyzed per condition) 
p.i. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001 by Student’s t-test.
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on activation and expansion of the T  cells have been studied 
broadly (2, 46, 47). However, it is unclear how affinity influences 
memory CD8 T cell formation. Herein, we studied three differ-
ent clones of CD8 T cells (R7-I, -II, and -III) during Toxoplasma 
infection in BALB/c mice. These three CD8 T cell clones harbor 
TCRs specific for the same peptide of the Toxoplasma protein 
ROP7, but differ in their sequence and affinity for that peptide 
presented in MHC class I (24, 25). The hierarchy of affinity and 
functional in vitro responsiveness to ROP7–MHCI of the clones 
was R7-I > R7-III > R7-II (25). The lowest affinity clone R7-II 
failed to traffic to the brain during the chronic phase of infec-
tion even though we could show acute phase proliferation. R7-I 
outperformed R7-III in persistence in lymphoid organs and the 
brain in chronic infection. In addition, R7-I was able to form 
more resident memory T cells in the brain than R7-III.
To test the affinity of the three R7 CD8 T cell clones in a more 
physiological setting, in addition to our previously published 3D 
affinity measurements, we performed 2D affinity measurements. 
Interestingly, we demonstrated little affinity difference between 
R7-I and R7-III. However, R7-I had a higher adhesion frequency 
than R7-III, possibly explaining the functional differences we 
observed between these clones in the chronic phase of infection.
R7-II, the clone with the lowest affinity for ROP7 peptide, was 
not found in the chronic state of Toxoplasma infection. Small 
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number of the cells of that clone got activated and proliferated in 
the acute phase of infection, but after the contraction phase that 
clone could not be found neither in any analyzed lymphoid organs 
nor in the brain. As one possible hypothesis, we demonstrated by 
RNAseq and subsequent qPCR that R7-II did not cross the affinity 
threshold required to downregulate Klf2 levels and consequently 
set the cells for homing to infected tissues. Lack of homing and 
retention in the LN as a mechanism responsible for lack of R7-II 
in brain was also supported by increased CTLA-4 expression. 
CTLA-4 expression on T cells is known to be responsible for cells 
being retained the LN after antigen encounter and mark anergic 
cells (48, 49). It is considered as one of T cell-intrinsic function 
of CTLA-4 to control self-reactive T cell motility in tissues (50). 
Signals from week TCR–MHC interaction may prevent full acti-
vation of the T cell, but still enable it to receive partial signals (2). 
Little is known about transcriptional regulation of Ctla-4 (51). It 
has not been investigated if Klf2 can directly or indirectly regulate 
Ctla-4 expression.
R7-I and R7-III clones were of higher affinity than the R7-II 
clone and both were found in the brain during the chronic phase 
of infection. The initially quite similar clones performed differ-
ently in the later phase of infection. While both clones were able 
to form SLEC and MPEC cells, the R7-III clone did not persist in 
the periphery and brain in the later phase of chronic infection. 
In addition, in the brain, more R7-I than R7-III cells showed a 
phenotype of resident-like memory cells (CD69+CD103+). We 
postulate that these differences can be attributed to the increased 
adhesion frequency we observed in 2D measurements, as well as 
the increased TCR–MHC binding affinity exhibited in 3D meas-
urements (25). We were not able to exactly pinpoint the reason 
for the disappearance of R7-III cells during the chronic phase of 
infection. It could be attributed to slower replication, higher rate 
of death, or formation of different types of cells that have different 
abilities to survive.
R7-III has been shown to be more proliferative than R7-I 
(more cell cycle terms in GO analysis) (25). Also, we observed 
slightly higher percentages of R7-III than R7-I cells in the spleen 
at 3 weeks p.i. indicating that the initial slower replication rate of 
R7-III is not the reason for differences between R7-I and R7-III 
observed in the later chronic phase of infection. SLEC and MPEC 
percentages were not significantly different between two clones. 
In addition, the expression of the exhaustion marker PD-1 and 
the ability to produce IFNγ also did not differ between R7-III and 
R7-I at 3 weeks p.i.
Creating BM chimeras, we provided an artificial model where 
R7-specific CD8 T cells are routed from the BM via the thymus to 
the periphery also during infection. This phenomenon has been 
described in persistent viral infections where host cells, but not 
donor cells, can be resupplied through thymic output, and new, 
naive specific CD8 T cells are being generated and subsequently 
primed during persistent infection (52). Newly generated T cells 
preserve antiviral CD8 T cell populations during chronic infec-
tion (52). In the C67BL/6 mice model of Toxoplasma infection 
T cells are recruited from the periphery to the brain in the chronic 
stage (41).
In our BM chimeras model, even if cells get exhausted or/
and stop dividing, new R7-specific cells are available to traffic 
to the brain. We concluded that constant replenishment from 
the periphery is necessary to keep the population of R7-III in 
the brain in the later stages of chronic infection. If the cells are 
available in the periphery they will traffic to the brain. Thus, since 
the R7-I clone exhibits longer survival in the periphery and in 
the brain, we can conclude that cells of stronger affinity perform 
better in chronic infections.
The proportion of the cells with TRM-like phenotype was dif-
ferent between R7-I and R7-III donor population in the brain. 
R7-III cells persistently exhibited a lower percentage of TRM-like 
cells, no matter if able to replenish from the periphery in BM chi-
meras or not. In addition, R7-III cells exhibiting the phenotype 
of resident-like memory T cells (CD69+CD103+) at 3 weeks p.i. 
were absent from the brain at 5 weeks p.i. This suggests that these 
were possibly not true (classical) TRM cells that are long lasting 
and shown to persist for years after infection. However, “classical” 
TRM were defined in acute infection models with rechallenge or 
persisting but latent virus infection (HSV) (20, 53–56). Beura 
et al. show that TRM from chronic infections differ from these ana-
lyzed in the acute infections with not only distribution in different 
non-lymphoid tissues but also expression of CD69 and CD103 
markers (57). It is thus conceivable that in chronic infection they 
may have a different characteristic. Constant antigen stimulation 
during persistent infection may have a negative influence on TRM 
that are considered to be antigen independent. Persistent antigen 
stimulation has been shown to lower CD103 expression on TRM 
but it did not block their formation (55). It is possible that these 
cells become exhausted when constantly stimulated and thus 
only newly formed CD103-positive cells contribute to the cells 
observed in the brain (23). The strength of the antigen stimulation 
can influence this process and lower affinity could lead to lower 
number of R7-III cells expressing CD103, eventually leading to 
the elimination of these cells. Indeed, it has been shown that TRM 
in the brain exhibit about 20-fold higher affinity as compared 
to splenic memory cells (33). As in our model R7-I and R7-III 
CD8 T cell differ in their TCR receptor, we propose that observed 
differences to persist as TRM-like cells are mostly due to cognate 
peptide affinity. One caveat is, however, that this difference may 
not only be derived from the affinity of the interaction with the 
cognate ROP7 peptide, but different TCRs may already shape the 
fitness of the cells differently in the thymus (25, 58). Indeed, we 
previously showed that R7-I and R7-III cell respond differently 
to CD3/CD28 stimulation with R7-III is being more prolifera-
tive. Thus, the self-reactivity of T cells may also play a role in the 
later stages of an infection in shaping the memory CD8 T cell 
phenotype.
Effector T cells in chronic infection are constantly exposed 
to antigen leading to exhaustion (59, 60). In the Toxoplasma 
infection model of C57BL/6 mice, it has been shown that 
chronic infection leads to exhaustion of CD8 T  cells in the 
brain (42, 61). However, C57BL/6 mice, unlike BALB/c mice 
are not resistant to Toxoplasma and die in the chronic phase of 
infection (42, 61). BALB/c mice, which we used in our model, 
are resistant to Toxoplasma and the chronic stage of infection 
is asymptomatic in this mouse strain. This implies that CD8 
T cells in the BALB/c model are not exhausted. Indeed, recently 
published data by Chu et al. show that CD8 T cells specific for 
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